Showing results (2071-2080 of 2,232) with videos related to
Sort By:
Pageof 224
Cell Reports Methods|October 5, 2023
RECOVER identifies synergistic drug combinations in vitro through sequential model optimizationPaul Bertin, Jarrid Rector-Brooks, Deepak Sharma, et al.Cell Host & Microbe|June 17, 2023
The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremiaJonas Schluter, Ana Djukovic, Bradford P Taylor, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|January 15, 2024
HerediGene Population Study IT infrastructure: A model to support genomic research recruitment and precision public healthDavid P Taylor, Bret S E Heale, Benjamin Chisum, et al.The Lancet. Infectious Diseases|November 10, 2021
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort studyAnika Singanayagam, Seran Hakki, Jake Dunning, et al.Bioorganic & Medicinal Chemistry Letters|June 11, 2005
Carboxylate bioisosteres of gabapentinCarmen E Burgos-Lepley, Lisa R Thompson, Clare O Kneen, et al.Haematologica|February 23, 2019
CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clusteringSimone C Oostindie, Hilma J van der Horst, Margaret A Lindorfer, et al.Epilepsia|October 24, 2006
Exploration of the genetic architecture of idiopathic generalized epilepsiesAnne Hempelmann, Kirsten P Taylor, Armin Heils, et al.Journal of Medical Internet Research|December 3, 2021
Open-source Software Sustainability Models: Initial White Paper From the Informatics Technology for Cancer Research Sustainability and Industry Partnership Working GroupYe Ye, Seemran Barapatre, Michael K Davis, et al.Blood|January 8, 2025
Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cellsSivasubramanian Baskar, Haiyong Peng, Erika M Gaglione, et al.Nature Genetics|August 14, 2023
In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesisDavid Lara-Astiaso, Ainhoa Goñi-Salaverri, Julen Mendieta-Esteban, et al.Pageof 224